Search - tctmd.com

Displaying 1 - 20 of 72

Sort: Relevancy | Date

Presentation TCT 2025

TCT 628: Ascending Aorta is the Key Predictor for Pure Native Aortic Regurgitation Patients Underwent Self-expandable Transfemoral Transcatheter Aortic Valve Replacement : From the Multicenter National NTCVR Database in China

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

The Transfemoral TaurusNXT TAVR System (Peijia Medical): Two-Year Results of the NXT-DURA Trial

Presenter: Wenzhi Pan

October 27, 2025

Presentation TCT 2025

TCT 1146: Transfemoral Transcatheter Aortic Valve Replacement in native aortic valves with small annuli: comparison of self-expandable and balloon-expandable vales.

Presenter: Kimberley Hemelrijk

October 25, 2025

Presentation TCT 2024

TCT 911: Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes

Presenter: Gijs Broeze

October 29, 2024

Presentation TCT 2024

TCT 906: Facilitated Transfemoral Versus Alternative Access Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease: Intra-Procedural and 30-Day Outcomes

Presenter: M. Abubakar Shakir

October 29, 2024

Presentation TCT 2024

TCT 897: Experience Using Brachiocephalic TAVI Access as an Alternative Option for Patients Unsuitable for Transfemoral or Left Subclavian Approach: A Two-Centre Series

Presenter: Hani Muradagha

October 28, 2024

Presentation TCT 2024

TCT 1395: Transfemoral Approach of TAVR in Patients With Prior Aortic Dissection: Two Case Studies

Presenter: ashrith garimella

October 28, 2024

Presentation TCT 2024

TCT 163: Self-Expandable Versus Balloon-Expandable Valves in Patients With Small Annuli Undergoing Transfemoral Transcatheter Aortic Valve Implantation

Presenter: Kimberley Hemelrijk

October 28, 2024

Presentation TCT 2024

TCT 153: Surgical Bailout in Transfemoral Transcatheter Aortic Valve Replacement: Insights From a Contemporary TAVR Cohort During the COVID-19 Pandemic

Presenter: Hugo Aarts

October 28, 2024

Presentation TCT 2023

TCT 705: Feasibility, Safety and Impact on Vascular Complication Management of Radial Use as an Ancillary Access During Transfemoral Transcatheter Aortic Valve Replacement: the TAVI-LITE Experience

Presenter: Enrico Romagnoli

October 26, 2023

Presentation TCT 2023

TCT 113: (Pre)clinical Case Studies of J-Valve Transfemoral System for Treating Large Annulus Aortic Regurgitation

Presenter: Dongming Hou

October 24, 2023

Presentation TCT 2022

TCT 791: Concomitant transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve-in-ring (TMViR) procedure with transfemoral approach

Presenter: Smitha Narayana Gowda

September 17, 2022

Presentation TCT 2020

TCT 612: Apical VSD and Left Ventricular Dissection Following Transfemoral Transcatheter Aortic Valve Replacement

Presenter: Malik Shehadeh

October 14, 2020

Presentation TCT 2020

TCT 485: Do Manufacturer's Derived Recommendations Predict Vascular Complications During Transfemoral TAVI Approaches Using Default Proglide Strategy?

Presenter: Beytullah Çakal

October 14, 2020

Presentation TCT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

Presenter: Vinod Thourani

September 27, 2019

Presentation TCT 2019

Large-Hole Transfemoral Closure III: The MANTA Device

Presenter: David Wood

September 27, 2019

Presentation TCT 2019

Large-Hole Transfemoral Closure II: The InSeal Device

Presenter: Ran Kornowski

September 27, 2019

Presentation TCT 2019

Large-Hole Transfemoral Closure I: The PerQseal Device

Presenter: Jeffrey Popma

September 27, 2019

Presentation TCT 2019

The Anatomically “Correct” Transfemoral JenaValve TAVR System

Presenter: Hendrik Treede

September 27, 2019

Advertisement

TCT 628: Ascending Aorta is the Key Predictor for Pure Native Aortic Regurgitation Patients Underwent Self-expandable Transfemoral Transcatheter Aortic Valve Replacement : From the Multicenter National NTCVR Database in China

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

The Transfemoral TaurusNXT TAVR System (Peijia Medical): Two-Year Results of the NXT-DURA Trial

TCT 1146: Transfemoral Transcatheter Aortic Valve Replacement in native aortic valves with small annuli: comparison of self-expandable and balloon-expandable vales.

TCT 911: Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes

TCT 906: Facilitated Transfemoral Versus Alternative Access Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease: Intra-Procedural and 30-Day Outcomes

TCT 897: Experience Using Brachiocephalic TAVI Access as an Alternative Option for Patients Unsuitable for Transfemoral or Left Subclavian Approach: A Two-Centre Series

TCT 1395: Transfemoral Approach of TAVR in Patients With Prior Aortic Dissection: Two Case Studies

TCT 163: Self-Expandable Versus Balloon-Expandable Valves in Patients With Small Annuli Undergoing Transfemoral Transcatheter Aortic Valve Implantation

TCT 153: Surgical Bailout in Transfemoral Transcatheter Aortic Valve Replacement: Insights From a Contemporary TAVR Cohort During the COVID-19 Pandemic

TCT 705: Feasibility, Safety and Impact on Vascular Complication Management of Radial Use as an Ancillary Access During Transfemoral Transcatheter Aortic Valve Replacement: the TAVI-LITE Experience

TCT 113: (Pre)clinical Case Studies of J-Valve Transfemoral System for Treating Large Annulus Aortic Regurgitation

TCT 791: Concomitant transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve-in-ring (TMViR) procedure with transfemoral approach

TCT 612: Apical VSD and Left Ventricular Dissection Following Transfemoral Transcatheter Aortic Valve Replacement

TCT 485: Do Manufacturer's Derived Recommendations Predict Vascular Complications During Transfemoral TAVI Approaches Using Default Proglide Strategy?

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

Large-Hole Transfemoral Closure III: The MANTA Device

Large-Hole Transfemoral Closure II: The InSeal Device

Large-Hole Transfemoral Closure I: The PerQseal Device

The Anatomically “Correct” Transfemoral JenaValve TAVR System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content